<!–*/ */ /*–>*/ For years, the green rush was virtually unstoppable — and it’s not hard to understand why. After legal weed sales more than tripled from $3.4 billion to $10.9 billion between 2014 and 2018, it seemed very feasible that Wall Street’s aggressive industry sales estimates, ranging from $50 billion to $200 billion in annual sales by 2030, would come true. However, 2019 turned into a wake-up call for pot stock investors, with a majority of cannabis stocks declining by a double-digit percentage. The losses were especially hard to swallow following a first quarter that saw more than a dozen marijuana stocks rise by at least 70%. Without digging too deeply into the weeds, it could be rightly argued that the following three popular cannabis stocks were the biggest disappointments of them all. The sad thing for the cannabis industry is that if there was one defining moment last year, it was the admission that Ontario-based CannTrust (NYSE: CTST) had grown marijuana illegally in five unlicensed rooms at its flagship Niagara campus for a period of six months (October 2018-March 2019). Until this early July admission, there had been a few co...